KFS
BHVN

Kelly Financial Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Kelly Financial Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-85
Closed -$12.8K – 713
2022
Q3 		$12.8K Hold
85
– – 0.01% 301
2022
Q2 		$12.4K Hold
85
– – 0.01% 301
2022
Q1 		$10.1K Hold
85
– – ﹤0.01% 339
2021
Q4 		$11.7K Hold
85
– – 0.01% 319
2021
Q3 		$11.8K Sell
85
-8,167
-99% -$1.02M 0.01% 312
2021
Q2 		$85K Buy
8,252
+8,167
+9,608% +$663K ﹤0.01% 400
2021
Q1 		$5.81K Hold
85
– – ﹤0.01% 382
2020
Q4 		$7.29K Hold
85
– – 0.01% 321
2020
Q3 		$5.53K Hold
85
– – ﹤0.01% 325
2020
Q2 		$6.21K Sell
85
-415
-83% -$22.1K ﹤0.01% 304
2020
Q1 		$17K Buy
+500
New +$22.9K 0.02% 153

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Kelly Financial Services's BHVN Position: Q4 2022 in Review

Kelly Financial Services sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 85 shares — an estimated $12.8K sold.

Kelly Financial Services first reported a position in BHVN in Q1 2020 and held it in 11 quarters. The position peaked at $85K in Q2 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Kelly Financial Services reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Kelly Financial Services sold 85 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $12.8K.
  • Kelly Financial Services first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 11 quarters.
  • Kelly Financial Services's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $85K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Kelly Financial Services's 13F filing for Q4 2022, filed 17 Jul 2024.